Parallax Volatility Advisers, L.P. Immuno Gen, Inc. Call Options Transaction History

Parallax Volatility Advisers, L.P.

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	BUY	$12.46 - $29.95 $6.71 Million - $16.1 Million	538,900 Added 1102.04%	587,800 $17.4 Million
Q3 2023 Nov 14, 2023	SELL	$14.09 - $19.87 $1.62 Million - $2.28 Million	-114,800 Reduced 70.13%	48,900 $776,000
Q2 2023 Aug 14, 2023	BUY	$3.75 - $20.05 $613,875 - $3.28 Million	163,700 New	163,700 $3.09 Million
Q4 2022 Feb 14, 2023	SELL	$4.55 - $6.31 $79,625 - $110,425	-17,500 Reduced 35.0%	32,500 $161,000
Q2 2022 Aug 15, 2022	SELL	$3.15 - $5.76 $114,660 - $209,664	-36,400 Reduced 42.13%	50,000 $225,000
Q1 2022 May 16, 2022	BUY	$4.26 - $7.48 $368,064 - $646,272	86,400 New	86,400 $411,000
Q2 2019 Aug 14, 2019	SELL	$1.8 - $3.3 $40,500 - $74,250	-22,500 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$2.41 - $5.91 $54,225 - $132,975	22,500 New	22,500 $61,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.